Wednesday,
September 16
September 16
10:00 – 10:15
Innovative Approaches for Challenging Drug Formulation
Latitude Pharma
10:15 – 10:30
From Preclinics to Commercial Launch: Building a Reliable European Supply Chain for Highly Potent APIs
Fermion
10:30 – 10:45
European CDMO: Securing Success for Clinical APIs and Intermediates
Kinsy
10:45 – 11:00
Recent cGMP Capability and Capacity Upgrades
Ryan Yoder
11:00 – 11:15
Beyond the Catalog – Cayman’s CDMO Services: A Trusted Partner from Molecule to Market
Cayman Chemical Company
11:15 – 11:30
The Strategic Value of Dedicated Process Research Expertise
Hande- Sciences
11:30 – 11:45
Tariff-Proof Your DS Sourcing: Leveraging Evonik’s US & European Supply Network
Evonik
11:45 – 12:00
MOEHS IBERICA, S.L
Helena Camps
12:00 – 12:15
Adesis
Ving Lee
Wednesday,
September 16 (cont)
September 16 (cont)
1:00 – 1:15
PepCellerate: Accelerate Timeline to Start PhI through Integrated Supply API-DP
Brian Case
1:15 – 1:30
Title_ TJ Sigler
Jubilant Biosys _
1:30 – 1:45
Crystallization. Polymorphs. Salts. Cocrystals.
Asha Pharma
1:45 – 2:00
Esteve
Esteve
2:00 – 2:15
Your Small molecule drug substance partner
DOTTIKON
2:15 – 2:30
PepCellerate: Accelerate Timeline to Start PhI through Integrated Supply API-DP
Brian Case- Corden
2:30 – 2:45
Chemvedals
Chemvedals
2:45 – 3:00
Jack Li
BirdoTech
3:00 – 3:15
Raffaella Fuccillo
Minakem
3:15 – 3:30
Nori Ikemoto
Porton
3:30 – 3:45
Wandi Zhang
AiFChem, an XtalPi Company
3:45 – 4:00
Jiuzhou Pharmace
Jiuzhou Pharmace
Thursday,
September 17
September 17
10:00 – 10:15
TCG Greenchem- Accelerating Molecules to Medicines via First Time Right Approaches
Gopal Sirasani
10:15 – 10:30
NFIL
Aditya Dilip
10:30 – 10:45
Quality without the Wait
Portrett Pharmaceuticals:
10:45 – 11:00
From Preclinics to Commercial Launch: Building a Reliable European Supply Chain for Highly Potent APIs
Fermion
11:00 – 11:15
Impurity Focused Small Molecule API Development: An Integrated R&D Approach
Robert Hughes
11:15 – 11:30
Jiuzhou Pharma: Innovative CDMO Solutions Featuring Our Peptide Technology Platform”
Juizho Pharma
11:30 – 11:45
Small Molecule CDMO Capabilities
Jubilant Ingrevia
11:45 – 12:00
Navigating the Multi-Modality Frontier: Integrated CDMO Solutions from Small Molecules to ADCs & Nucleic Acids
Cohance

